HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Kyowa Kirin Co., Ltd.

1
Articles
Mentioned
Top Role
Apr 9, 2026
First Mention
Apr 9, 2026
Last Mention
0.73
Relevance Score

Coverage Timeline

April 2026
Eli Lilly's $2.4 Billion DICE Therapeutics Bet: Pipeline Risk, Platform Ambition, and Autoimmune Expansion Deals Mentioned
Apr 9, 2026
Amgen’s $1.6 billion Kyowa Kirin deal structured heavy milestone payments to de-risk the buyout.
Related Companies
Arena Pharmaceuticals, Inc.
1 shared
DICE Therapeutics, Inc.
1 shared
Amgen Inc.
1 shared
Novartis AG
1 shared
Eli Lilly and Company
1 shared
Pfizer Inc.
1 shared